Diagnósticos da América is leaning into premium tests, at-home services, and partnerships with large health insurers to try to lift demand and improve profitability over time. The flip side is that debt, execution missteps from closing locations, or a souring relationship with a key partner could quickly derail the turnaround.Read more

Ecopetrol is pushing hard on efficiency and new energy projects while keeping output high, a mix that could help it hold up better when oil prices swing. The catch is that big long-lead projects and Colombia’s policy and regulatory backdrop could delay results or squeeze cash, so the upside depends on how smoothly these plans land.Read more

Revolution Medicines is betting on a new wave of more precise cancer drugs aimed at hard-to-treat tumors linked to RAS mutations, and it already has a large set of late-stage studies running. The big question is whether those studies turn into approvals and real-world adoption fast enough to justify the heavy spending needed before the first product reaches patients.Read more

Figure Technology Solutions aims to use blockchain and newer “crypto-style” funding tools to make consumer lending faster and more efficient, shifting from holding loans to earning fees by connecting lenders with big investors. The upside depends on more banks and lenders using its marketplace and stablecoin products, but a slowdown in adoption or tougher rules could quickly change the story.Read more

A little-known medical device maker could get a big lift as insurers and government programs cover more testing for swelling after cancer treatment and for people with heart failure. The key question is whether hospitals move fast enough and testing demand holds up to turn those coverage wins into steady subscription-like revenue.Read more

Catalysts About Grupo de Inversiones Suramericana Grupo de Inversiones Suramericana is a Colombia based financial group focused on insurance, asset and wealth management and banking through its core holdings. What are the underlying business or industry changes driving this perspective?Read more

Tongcheng Travel is betting that Chinese travellers keep taking more trips and trading up to better hotels, while its growing hotel management arm becomes a bigger profit engine. The upside rests on new holiday patterns, deeper AI-powered booking help, and traffic from Tencent, but the story changes quickly if travel demand cools or users shift to other booking channels.Read more

Nick Scali is betting it can turn its struggling U.K. business around while riding the growing shift to buying furniture online, which could reshape how reliable its profits look. The big question is whether revamped U.K. stores and a revamped delivery setup can lift sales enough without squeezing prices or margins at home.Read more

IPG Photonics looks set to benefit as factories automate and electric-vehicle and electronics makers ramp up production, with new laser products gaining traction faster than many expected. The upside is real, but the story also depends on holding up against supply-chain disruption, tighter rules, and cheaper rivals that could chip away at demand and pricing.Read more